NEA 13 GP, Ltd
CIK 1460751 · last filed 2021-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CVT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BALTIMORE, MD 21202
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COUR | 10%+ Owner | 15,059,911 | $3.73 | $56.25M | $0 | 1 | 2021-05-21 |
| SPT | 10%+ Owner | 3,082,854 | $11.00 | $33.91M | $0 | 1 | 2020-11-17 |
| NET | 10%+ Owner | 6,804,306 | $271.42 | $1.85B | $0 | 2 | 2020-11-13 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 0 | — | — | $4.39M | 2 | 2020-04-03 |
| Care.com Inc (CRCM) Delisted | 10%+ Owner | 2,256,013 | — | — | $0 | 1 | 2017-11-08 |
| RYTM | 10%+ Owner | 4,909,956 | $111.26 | $546.28M | $9.35M | 1 | 2017-10-10 |
| Roka BioScience, Inc. (ROKA) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2016-09-30 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 406,500 | $1.47 | $597.6K | $10.00M | 1 | 2016-01-12 |
| BOX | 10%+ Owner | 2,091,457 | $42.17 | $88.20M | $0 | 1 | 2015-01-29 |
| CVENT INC (CVT) Delisted | 10%+ Owner | 3,994,106 | $8.52 | $34.03M | -$40.21M | 3 | 2014-11-28 |
| TESARO, Inc. (TSRO) Delisted | 10%+ Owner | 9,854,255 | — | — | $15.00M | 2 | 2013-06-05 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 2,291,180 | $0.08 | $186.0K | $0 | 1 | 2013-06-05 |
| Millennial Media Inc. (MM) Delisted | 10%+ Owner | 8,196,614 | — | — | -$21.48M | 1 | 2012-10-30 |
Recent Filings · Page 2 of 2
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-29 | BOX | Mixed | −162,780 | $0 | EDGAR |
| 2014-11-28 | CVENT INC (CVT) Delisted | Other (J) | −1,000,000 | $0 | EDGAR |
| 2014-08-18 | CVENT INC (CVT) Delisted | Other (J) | −1,000,000 | $0 | EDGAR |
| 2014-01-21 | CVENT INC (CVT) Delisted | Sell (S) | −1,132,589 | -$40.21M | EDGAR |
| 2013-06-05 | TESARO, Inc. (TSRO) Delisted | Other (J) | −1,645,000 | $0 | EDGAR |
| 2013-06-05 | Clovis Oncology, Inc. (CLVS) Delisted | Other (J) | −1,139,890 | $0 | EDGAR |
| 2013-04-17 | — | Mixed | +5,833,213 | $10.07M | |
| 2012-10-30 | Millennial Media Inc. (MM) Delisted | Sell (S) | −1,597,787 | -$21.48M | EDGAR |
| 2012-07-03 | TESARO, Inc. (TSRO) Delisted | Mixed | +11,499,255 | $15.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.